Colinz Laboratories Ltd Board Meeting on Oct 29 to Approve Q2 Results

Colinz Laboratories Ltd has announced that its Board of Directors will convene on October 29, 2026, to consider and approve the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026. The company also informed that the trading window for dealing in its equity shares has been closed from October 01, 2026, and will remain closed until 48 hours after the communication of the financial results. This closure is in accordance with the company's Code of Conduct for Prevention of Insider Trading.